Affiliation:
1. Patna Medical College, Patna, Bihar, India
2. P
Abstract
This prospective drug trial was done to compare latanoprost versus combination therapy of latanoprost and timolol maleate. Patient were screened for primary open angle glaucoma and grouped as per pharmacological drugs used and measured IOP baseline before initiation of study. Group I consisting all patients with latanoprost monotherapy and Group II consisting of patients already using either latanoprost or timolol. Further A,B & C was assigned as per IOP baseline. In group I (Monotherapy), 28 patients were completed the follow up. The mean baseline IOP was 27.4 millimeter of Hg with standard deviation of 2.59. After 12 weeks of study, mean IOP was 19.66 millimeter of Hg with SD of 2.76. Mean IOP difference from baseline was 7.4 millimeter of Hg. So fall of 27.3% in IOP from pre-treatment level. In group II (Combination therapy), 19 patients were completed the follow up. The mean baseline IOP was 27.35 millimeter of Hg with standard deviation of 2.6. After 12 weeks of study mean IOP difference from baseline was 8.1 millimeter of Hg with SD of 2.0 millimeter of Hg i.e. a fall of 29.63% in IOP from pre-treatment level. Combination therapy fared slightly better that Latanoprost alone in overall pressure reduction.
Publisher
IP Innovative Publication Pvt Ltd
Reference10 articles.
1. American Academy of Ophthalmology. Primary Open-Angle Glaucoma. Preferred Practice Pattern. San Francisco, CA: American Academy of Ophthalmology..
2. A 6-week, double-masked, paralle-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension
3. Fixed Combination of Latanoprost and Timolol vs Individual Components for Primary Open-Angle Glaucoma or Ocular Hypertension
4. A Agarwal, N Agarwala, R Chandra, GS Dhami, R Dhesi, PN Kendra, Open Label, Prospective, Multicentre Indian Study of Latanoprost in Primary Open Angle Glaucoma and Ocular Hypertension..
5. A Comparison of Latanoprost and Timolol in Primary Open-angle Glaucoma and Ocular Hypertension